1. Barry F P, Murphy J M. (2004). Mesenchymal stem cells: Clinical applications and biological characterization Int. J. biochem. Cell Biol, 36(4): 568-584.
2. Chen F, Tuan R. (2008). Mesenchymal stem cells in arthric disease Arthric Res Ther, 10(5): 223.
3. Magana-Guerrero F, Dominguez-Lopez A, Martinez-Aboytes P, Buentello-Volante B, Yonathan-Garfas B. (2017). Human Amniotic Membrane Mesenchymal Stem Cells inhibit Neutrophil Extracellular Traps through TSG-6. SCLenTIFIC REPORTS, 7:12426. 10.1038/s41598-017-10962-2.
4. Zhang D, Jiang M, Miao D. (2011). Tranplanted humen amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse. PLoS One, 6(2): e16789.
5. Friedenstein A J, Piatetzky S, Petrakova K. (1966). Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol, 16: 381-390.
6. Lu L-L, Liu Y-J, Yang S-G, Zhao Q-J, Gong W, al. e. (2006). Isolation and characterization of human unbilical cord mesenchymal stem cells with hematopoiesis supprotive function and other potentials. Haematologica, 91(8): 1017-1026.
7. Da-Silva-Meirells L, Chagastelles P C, Nardi N B. (2006). Mesenchymal stem cells reside in virtually all postnatal organs and tissues. J Cell Sci, 119: 2204-2213.
8. dominici M, le Blanc K, Mueller L, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international Society for Cellular Therapy position statement. , Cytotherapy 8: 315-317.
9. Miao Z, Jin j, Chen L, Zhu J, Huang W, Zhao J. (2006). Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrw mesenchymal stem cells. Cell Biol Int, 30(9): 981-987.
10. Scherjon S, Kleijburg-van der keur C, De-Groot-Swings G, Claas F, Fibbe W, Kanhai H. (2004). Isolation of mesenchymal stem cells of fetal and materna origin from human placenta. Stem Cells, 22(7): 1338-1345.
11. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao R. (2005). Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun, 332(2): 370-379.
12. Diaz-Prado S, Muinos-Lopez A, Harmida-Gomez T, Rendal-Vazquez M, Fuentes-Boquete I, Francisco J. (2011). Isolation and characterization of mesenchymal cells from human amniotic membrane Tissue Engineering Part-C: Methods., 17(1): 49-59.
13. Motedayyen H, Esmaeil N, Tajik N, Khadem F, S. G, Khani B, Rezaei A. (2017). Method and key points for isolation of human amniotic epithelial cells with high yield, viability and purity. BMC Res Notes, 10(552). 10.1186/s13104-017-2880-6
14. Razavi-Tousi M T, Amirizadeh N, Nasirinezhad F, Nikougoftar F, Ganjibkhsh M, Aboutaleb N. (2017). A rapid and cost-effective protocol for isolating mesnchymal stem cells from human amniotic membrane. GMJ, 6(3): 217-225.
15. Tsuji H, Miyoshi S, Ikegami Y, Hida N, Asada H, Togashi I. (2010). Xenografted human amniotic membrane-derived mesenchymal stem cells are immounologically tolerated and transdiffentiated into cardiomyocytes. Circul Res, 106(10): 1613-1623.
16. Kimotoshi K, Shunsuke O, Hidetaka H, Moto F, Ayano K, Ryosuke H, Takahiro Y, Reiz O, Kinichi Y, Hiroshi T, Naoya S. (2015). Human amniotic-derived mesenchymal stem cell transplantation ameliortes liver fibrosis in Rats. The Transplantation Society, 1(e16). 10.1097/TXD.0000000000000525
17. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, al. e. (2007). Term amniotic membrane is a high throughput source for multiputent mesenchymal stem cells with the ability to diffenrentiate into endothelial in vitro. DMC Dev Biol, 21(4): 11.
18. Kim S, Zhang H Z, Kim C E, An J M, Kim M H. (2012). Amniotic mesenchymal stem cells have rebust angiogenic properties and are effective in treating hindlimb ischaemia. Cardiovacular Research, 39(3): 525-534.
19. Solomon A, Wajngarten M, Alviano F, Anteby I, Elchalal U, peer J, al. e. (2005). Suppression of inflammatory and fibrotic responses in an in-vito model of allergic inflammation by the amniotic membrane stromal matrix. Clin Exp Allergy, 35(7): 941-948.
20. Dua H, Gomes J, King A, Maharajan V. (2004). The amniotic membrane in ophthalmolog. Surv Ophthalmol., 49(3): 51-77.
21. Chavez-Garcia C, al. e. (2016). Ophtalmic indications of amniotic membrane transplantation in Maxico: an eight years Amniotic Membrane Bank experience. Cell Tissue Bank, 17: 261-268.
22. Noth U, Steinert A, Tuan R. (2008). Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Rev Rheumatol, 4(7): 371-380.
23. Ono M, al. e. (2015). Effects of human amnion-derived mesenchymal stromal cell transplantion in rats with radiation proctitis. Cytotherapy, 17: 1545-1559.
24. alviano F, Fossati V, Marchionni C, Arpinati M, Franchina M. (2007). Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in-vitro. BMC Dev Biol, 21(7): 11.
25. Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A. (2007). Isolation and characterization of mesenchymal stem cells from human fetal membranes. J Tissue Eng Regen Med, 1(4): 296-305.
26. Toda A, Okabe M, Yoshida T, Nikaido T. (2007). The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci, 105: 215-228.
27. Murphy S, Kidpoor A, Reid T, Atala A, Wallace E, Lim R. (2014). Isolation, cryopreservation and culture of human amniotic epithelail cells for clinical applications. J Vis Exp, org/10.3791/52085.
28. Mihu C M, Rus-Ciuca D, Soritau O, Susman S, Mihu D. (2009). Isolation and characterization of mesenchymal stem cells from the amniotic membrane. Morphology and Embryology, 50(1): 73-77.
29. Parolini O, al. e. (2008). Concise review: Isolation and characterization of cells from human term placenta outcome of the first international workshop on placenta derived stem cells. Stem Cells, 26: 300-311.
30. Kaboyashi M, Yakuwa T, Sasaki K, Sato K, Kikuchi A, Kamo I, Yokoyama Y, Sakuragawa N. (2008). Multilineage potential of side population cells from human amniotic mesenchymal layer. Cell Transplant, 17: 291.
31. Tamagawa T, Ishikawa H, Nakamura Y. (2008). Induced in-vitro differentiation of neurallike cells from human amnion-derived fibroblast-like cells. Hum Cell, 21: 38.